Q1 FY26-27 PAT up about 17% YoY, revenue grows 45%

Revenue Growth 20pctResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.6%Reaction day

₹83.99

prior close

₹86.99

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.5%+3.2% vs market

Non Banking Financial Company (NBFC) peers, median of 220sector+0.1%+3.5% vs sector

On the reaction day the stock moved 3.2 pts more than Nifty Microcap 250 and 3.5 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.9

10m

-3.3

15m

-3.3

30m

-4.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.6+0.5+3.2+0.1+3.5

Next day

+4.1-0.1+4.2-0.1+4.2

+4.8+1.0+3.8+0.6+4.2

+5.4+2.3+3.0+0.4+4.9

+5.8+2.8+3.1+1.2+4.6

+6.3+4.1+2.2+1.4+4.9

+9.5+4.5+5.0+0.5+9.0

15d

-1.3+4.8-6.1+0.0-1.3

+1.9+6.4-4.6+0.5+1.4

+2.2+5.5-3.3-1.4+3.6

+17.9pendingpending-4.3+22.2

UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 220Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY26-27 revenue from operations rose about 45 percent YoY to about Rs 14.79 crore, led by fees and commission income of about Rs 10.98 crore and net gain on fair value changes of Rs 2.55 crore. PAT grew about 17 percent YoY to about Rs 4.41 crore versus Rs 3.77 crore, with EPS at Rs 2.18. Sequentially, PAT jumped sharply from Rs 0.36 crore in Q4 FY25-26. Bad debts rose to about Rs 3.10 crore from Rs 1.80 crore a year ago and impairments rose too. No dividend declared. Auditor Darpan and Associates issued an unqualified limited review.

Likely market impact

Strong revenue growth and sharp QoQ PAT recovery signal improving momentum, but rising bad debts and impairments are a watch point for investors.